Early Diagnostic Solutions for Gynecological Disease
Nevia Bio is an innovative health technology company committed to transforming women's health through the discovery of biomarkers in vaginal fluid. Our mission is to develop non-invasive, AI-driven diagnostic solutions for early detection of gynecological cancers, with an initial focus on ovarian cancer.
By leveraging the world’s largest database of vaginal fluid and multi-omics data, Nevia Bio is pioneering a breakthrough diagnostic platform that has the potential to detect cancers at their earliest and most treatable stages, ultimately improving patient outcomes and reducing treatment costs.
| Name | Nevia bio |
|---|---|
| Slug | nevia-bio |
| Former names | Gina Life |
| Type / kind | startup |
| Crunchbase ID | gina-life-diagnostics |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwKXi7s0IDA |
| Status | active |
|---|---|
| Last update | 2026-05-17 |
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Haifa |
| HQ address | Nahum Het St 7, Haifa, Israel |
| Website | https://www.nevia.bio/ |
|---|---|
| https://www.linkedin.com/company/34901626 | |
| https://www.facebook.com/profile.php?id=100032894334239 |
| Total raised | $5.0M |
|---|---|
| Current stage | Seed |
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}